Speakers
(In alphabetical order)
Kari Alitalo |
(University of Helsinki, Finland) |
|---|---|
Hartmut Beug |
(IMP Vienna, Austria) |
Frank Buchholz |
(MPI Dresden, Germany) |
Hermann Bujard |
(EMBO Executive Director, Germany) |
Gerard Christofori |
(Institute of Biochemistry and Genetics, University of Basel, Switzerland) |
Gerard I. Evan |
(Comprehensive Cancer Center, UCSF, San Francisco, US) |
Peter Friedl |
(Cell Biology Dept., , Radboud University, Nijmegen, The Netherlands) |
Magdalena Götz |
(GSF Neuherberg, Germany) |
Laura Johnston |
(Columbia University Medical Center New York, USA) |
Jos Jonkers |
(Netherlands Cancer Center, Amsterdam, The Netherlands) |
Frank Lyko |
(DKFZ Heidelberg, Germany) |
Chris J. Marshall |
(Institute of Cancer Research, London) |
Eduardo Moreno |
(Spanish National Cancer Research Center Madrid, Spain) |
Pier G. Pelicci |
(IFOM-IEO, Milan, Italy) |
Ulf R. Rapp |
(MSZ Wuerzburg, Germany) |
Ralf Schnabel |
(Developmental Genetics TU Braunschweig, Germany) |
Somasekar Seshagir |
(Genentech, USA) |
Claudio Stern |
(University College London, UK) |
Thorsten Stiewe |
(Institute of Molecular Biology and Tumor Research, Marburg, Germany) |
Elly M. Tanaka |
(MPI Molecular Cell Biology and Genetics Dresden, Germany) |
Andreas Trumpp |
(ISREC, Epalinges, Switzerland) |
Maarten von Lohuizen |
(Netherlands Cancer Center, Amsterdam, The Netherlands |
Fiona Watt |
(Cancer Research UK Cambridge, UK) |
Yosef Yarden |
(Weizmann Institute Rehovot, Israel) |





